Research
Energy balance
Efsubaglutide Alfa produced a mean weight reduction of 7.16% versus 0.86% with placebo.
Efsubaglutide Alfa may be an effective treatment option for weight loss in individuals with obesity or overweight.
StrongSupportsmedium confidence
Efsubaglutide Alfa produced a mean weight reduction of 7.16% (95% CI: -8.08 to -6.24) versus 0.86% with placebo.
Why this rating
Based on the randomized, double-blind, placebo-controlled trial design.
Source
Efficacy, tolerability, and safety of Efsubaglutide Alfa in participants with obesity or overweight ( <scp>LIGHT</scp> 1): A randomized, double‐blind, placebo‐controlled, ascending‐dose phase 2a trial
Fei Gao et al. · Diabetes Obesity and Metabolism · 2026
DOI 10.1111/dom.70429
rct · n=50
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →